Home
About Us
R&D Pipeline
Research Progress
News
Contact Us
Investor Relations
繁体
澳門超科生物醫藥有限公司
MACAU SUPRASCIENCE BIOMEDICINE CO.,LTD.
Openness & Cooperation
Support the next generation of cell therapies through strategic collaboration.
Currently, there are no living cell drug delivery preparations in the world. The advantages of supramolecular cell delivery technology, such as simple, mild, non-invasive to cells and clear drug mechanism, will define the field of cellular drug delivery preparations in the world. The launch of new cell therapy technology is expected to occupy the cancer market of chemotherapy drugs.

Project future planning


● Recruitment of key personnel

● Preclinical studies: third-party safety studies and technical effectiveness studies of CRO

● Commission of Health, investigator-initiated Clinical Trial (IIT)

● Preparation before IND filing

● Other novel Drug candidate development (POC)

澳門超科生物醫藥有限公司
About Us
Research Progress
MACAU SUPRASCIENCE BIOMEDICINE CO.LTD.
Tel: 68080332 (Miss Wei)
E-mail: 396447219@qq.com
Wechat: 13078617009 (Miss Wei)
Company address: Room 1010, 1 Floor, Juxian Building, University of Macau, Mingde Da Lu, Taipa, Macau
News
Introduction
Team Member
Cooperation
Research Results
Technology Platform
Contact us
Investor Relations
© 2023 MACAU SUPRASCIENCE BIOMEDICINE CO.,LTD. All rights reserved.
Powered by Feedback Manage